drug · small molecule
roflumilast
pre_registrationupdated 3mo agoby $ARQT Arcutis Biotherapeutics, Inc.🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 2Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 20 investigational indications.
targets
Phosphodiesterase 4
all catalysts(0)
nothing on the calendar yet
Trials studying roflumilast
- phase3Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study
- phase3Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)
- phase3Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)
- phase3A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
- phase2A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD
- phase3Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)
- phase2A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa
- phase3Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 57m ago
Found something off?
comments(0)
5-min edit window · permanent after that